Effect of Lvsolecithin and Analogs on Mouse Ascites Tumors

Cancer Research

Volumn 38, Issue 2, 1978, Pages 339-344

  Tarnowski, George S ^a   Mountain, Isabel M ^a   Stock, C Chester ^a   Munder, Paul G ^a   Weltzien, Hans U ^a   Westphal, Otto ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE; HEXADECYL 3 PHOSPHORYLCHOLYLPROPANEDIOL; HYAMINE HYDROXIDE; LYSOLECITHIN DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ASCITES TUMOR; CANCER CHEMOTHERAPY; CANCER GRAFT; CANCER GROWTH; DOSE RESPONSE; DRUG COMPARISON; DRUG RESPONSE; FIBROSARCOMA; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CARCINOMA, EHRLICH TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROSARCOMA; LYSOPHOSPHATIDYLCHOLINES; MALE; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; SARCOMA, EXPERIMENTAL; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; TIME FACTORS;

EID: 0018150545     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Akersson, B., Arner, A., and Sundler, R. Metabolism of Different Mon-oacylphospholipids in Isolated Hepatocytes and the Intact Rat. Biochim. Biophys. Acta, 441: 453–464, 1976.
2. Arnold, D., and Weltzien, H. U. Über die strukturabhängige hämolytische Aktivitat einiger Cholin-Phosphatide. Z. Naturforsch., 23b: 675–683, 1967.
3. Arnold, D., Weltzien, H. U., and Westphal, O. Über die Synthese von Lysolecithinen und ihren Atheranaloga. Liebigs Ann. Chem., 709: 234–239, 1967.
4. Eible, H., and Westphal, O. Palmitoyl-propandiol-(1, 3)-phosphorylcholin (2-desoxy-lysolecithin) und ω.ω-Alkandiol-Analoga. Liebigs Ann. Chem., 709: 244–247, 1967.
5. Fischer, H. Lysolecithin and the Action of Complement. Ann. N. Y. Acad. Sci., 116: 1063–1070, 1964.
6. Kay, E. R. M. Effects of Tween 80 on the Growth of the Ehrlich-Lettré Ascites Carcinoma. Experientia, 21: 644–645, 1965.
7. Klibansky, C., Smorodinsky, I., and de Vries, A. Action of Lysolecithin on Normal and Leukemic Human Leukocytes. Med. Pharmacol. Exptl., 16: 297–304, 1967.
8. Langer, W. Untersuchungen zum Wirkungsmechanismus immunologischer Adjuvantien. Doctoral Thesis, University of Freiburg i. Br., Germany, 1973.
9. Mehrishi, J. N., and Butterworth, A. E. Murine Ascites Tumour Cells and Lymphocytes. Effect of Lysolecithin, Organic Mercurials and an Antitumoral Agent on the Cell Membrane Permeability. European J. Cancer, 5: 5-14, 1969.
10. Munder, P. G., Ferber, E., Modolell, M., and Fischer, H. The Influence of Various Adjuvants on the Metabolism of Phospholipids in Macrophages. Intern. Arch. Allergy Appl. Immunol., 36: 117-128, 1969.
11. Munder, P. G., Fischer, H., Weltzien, H. U., Oettgen, H. F., and Westphal, O. Lysolecithin Analogs: A New Class of Immunopotentiators with Antitumor Activity. Proc. Am. Assoc. Cancer Res., 17: 174, 1976.
12. Munder, P. G., Weltzien, H. U., and Modolell, M. Lysolecithin Analogs: A New Class of Immunopotentiators. In: P. S. Miescher (ed.), Immunopathology (7th International Symposium), pp., 411–424. Stuttgart: Schwabe and Co., GmbH, 1976.
13. Schmid, F. A., Cappuccino, J. G., Merker, P. C., Tarnowski, G. S., and Stock, C. C. Chemotherapy Studies in an Animal Tumor Spectrum. I. Biologic Characteristics of the Tumors. Cancer Res., 26 (Part 2): 173–180, 1966.
14. Stein, Y., and Stein, O. Metabolism of Labeled Lysolecithin, Lysophos-phatidylethanolamine and Lecithin in the Rat. Biochim. Biophys. Acta, 116: 95–117, 1966.
15. Tarnowski, G. S. Approaches to the lmmunotherapy of Experimental Tumors. In: D. Mizuno et al. (eds.), Host Defense against Cancer and Its Potentiation, pp. 390–396. Tokyo: University of Tokyo Press, 1975.
16. Weltzien, H. U., and Westphal. O. O-Methylierte und O-Acetylierte Lysolecithine. Ann. Chem., 709: 240-243, 1967.